ספלוטן
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
TAFLUPROST 15 MCG/ML
Disponibbli minn:
MERCK SHARP & DOHME ISRAEL LTD
Kodiċi ATC:
S01EE05
Għamla farmaċewtika:
OPHTHALMIC SOLUTION
Rotta amministrattiva:
OCULAR
Manifatturat minn:
MERCK SHARP & DOHME B.V, HOLLAND
Grupp terapewtiku:
TAFLUPROST
Indikazzjonijiet terapewtiċi:
Reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.As monotherapy in patients • who would benefit from preservative free eye drops • insufficiently responsive to first line therapy • intolerant or contra-indicated to first line therapyAs adjunctive therapy to beta-blockers.
Data ta 'l-awtorizzazzjoni:
2011-12-01
